The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Self-Injections Market By The End Of 2030?
The self-injections market has seen substantial expansion in recent years. Its valuation is set to increase from $10.22 billion in 2025 to $11.04 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.1%. This past growth can be ascribed to an uptick in chronic disease prevalence, wider availability of injectable biologics, a growing inclination for home-based treatment, the broadening of specialty pharmaceuticals, and enhancements in injection device ergonomics.
The self-injections market is projected for significant expansion over the coming years. Its valuation is set to reach $15.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. This anticipated growth is driven by several factors, including the rising need for self-care treatments, wider acceptance of digital health-integrated injectors, the expanding development of biologic medications, a heightened emphasis on drug delivery systems that improve patient adherence, and the growing application of connected medical devices. Key trends expected during this period involve the greater uptake of auto-injector devices, increasing demand for wearable injection solutions, the expanding utilization of self-administered biologic therapies, the development of more patient-focused drug delivery designs, and a stronger emphasis on ensuring both safety and precise dosage.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8235&type=smp
Which Market Drivers Are Supporting The Expansion Of The Self-Injections Market?
The increasing count of individuals diagnosed with diabetes is anticipated to propel the expansion of the self-injections market moving forward. Diabetes is a medical condition where the pancreas, an organ in the human body responsible for insulin creation, fails to produce sufficient insulin. This leads to the buildup of blood sugars and can result in severe health complications such as heart disease, vision loss, and kidney diseases. Self-injections offer diabetic patients a method to administer insulin and other necessary medications, helping to maintain optimal blood sugar levels and prevent excessive blood sugars at any given moment, without requiring a medical professional’s aid. For instance, in November 2025, data from Diabetes Care, a US-based international peer-reviewed medical journal, revealed that an estimated 634.8 million adults, representing 12.0 percent of the global adult population, were living with impaired glucose tolerance in 2024. This number is projected to climb to 846.5 million adults, or 12.9 percent of the world’s adult population, by 2050. Thus, the rising number of diabetic patients is a key factor driving the growth of the self-injections market.
Which Segment Classifications Shape The Self-Injections Market?
The self-injections market covered in this report is segmented –
1) By Type: Devices, Formulations
2) By Dosage: Single Dose, Multi Dose
3) By Application: Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Pain Management, Other Applications
4) By Distribution Channel: Chemist, Online Pharmacies
Subsegments:
1) By Devices: Pre-Filled Syringes, Auto-Injectors, Microneedle Devices, Wearable Injectors
2) By Formulations: Biologics, Small Molecules, Combination Products
How Are Trends Impacting The Self-Injections Market?
Companies operating in the self-injections market are heavily investing in drug delivery innovations, specifically hands-free, hidden-needle subcutaneous methods, to simplify the self-administration of large-volume biologics for patients. Such delivery systems refer to wearable injectors that discreetly dispense medication without requiring manual action, while keeping the needle concealed to enhance comfort and safety. For instance, in November 2023, Enable Injections Inc., a US-based drug-delivery technology firm, obtained its first US Food and Drug Administration (FDA) approval for the enFuse large-volume wearable injector, designed for use with EMPAVELI (pegcetacoplan). This compact, mechanical, body-worn system can deliver up to 25 mL subcutaneously, supporting both self-administration and in-clinic use with features such as hands-free operation and reduced interruption to patients’ daily routines. The enFuse platform significantly boosts convenience, enables home-based care, and generally improves the patient experience for large-volume therapy delivery.
Which Companies Are Expanding Their Footprint In The Self-Injections Market?
Major companies operating in the self-injections market are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT LTD, Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.
Read the full self-injections market report here:
https://www.thebusinessresearchcompany.com/report/self-injections-global-market-report
How Is The Self-Injections Market Distributed Across Key Geographic Regions?
North America was the largest region in the self-injections market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Self-Injections Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8235&type=smp
Browse Through More Reports Similar to the Global Self-Injections Market 2026, By The Business Research Company
Injection Pen Market Report 2026
https://www.thebusinessresearchcompany.com/report/injection-pen-global-market-report
Chemical Injection Pumps Market Report 2026
https://www.thebusinessresearchcompany.com/report/chemical-injection-pumps-global-market-report
Chemical Injection Skids Market Report 2026
https://www.thebusinessresearchcompany.com/report/chemical-injection-skids-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model